158
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Tailored release drug delivery system for Rifampicin and Isoniazid for enhanced bioavailability of Rifampicin

&
Pages 127-136 | Received 13 Sep 2009, Accepted 20 Nov 2009, Published online: 27 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tarun Garg, Amit K. Goyal, Goutam Rath & R. S. R. Murthy. (2016) Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation. Pharmaceutical Development and Technology 21:8, pages 951-960.
Read now
Yongjun Wang, Hongzhuo Liu, Kai Liu, Jin Sun & Zhonggui He. (2013) Design and evaluation of enteric-coated tablets for rifampicin and isoniazid combinations. Pharmaceutical Development and Technology 18:2, pages 401-406.
Read now

Articles from other publishers (9)

Saade Abdalkareem Jasim, Mohammed Sabar Al-Lami, Ameer A. J, A.H. Shather, Ahmed Khalid Aldhalmi, Anmar Ghanim Taki, Batool Ali Ahmed, Mais Mazin Al-Hamdani & Shelesh Krishna Saraswat. (2024) Nanostructures of boron nitride: A promising nanocarrier for anti-cancer drug delivery. Micro and Nanostructures 185, pages 207708.
Crossref
Yan Cao, Sagr Alamri, Ali A. Rajhi, Ali E. Anqi & Maryam Derakhshandeh. (2022) The capability of boron carbide nanotube as a nanocarrier for fluorouracil anticancer drug delivery; DFT study. Materials Chemistry and Physics 275, pages 125260.
Crossref
Filipa Santos & Ana Rita C. Duarte. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 173 210 .
Yan Cao, Hayder A. Dhahad, Hasanen M. Hussen, Ali E. Anqi, Naeim Farouk, Alibek Issakhov, Nai-Yuan Xu & Maryam Derakhshandeh. (2021) NC3 carbon-like nanotube as promising nanocarriers for anticancer drugs delivery; density functional theory studies. Journal of Molecular Liquids 340, pages 117221.
Crossref
Laura Carolina Luciani-Giacobbe, Augusto Matías Lorenzutti, Nicolás Javier Litterio, María Verónica Ramírez-Rigo & María Eugenia Olivera. (2020) Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid. Drug Delivery and Translational Research 11:3, pages 894-908.
Crossref
Boi-Lam Hong, Ronilda D'Cunha, Peizhi Li, Mohammad H. Al-Shaer, Wael A. Alghamdi, Guohua An & Charles Peloquin. (2020) A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis. Clinical Therapeutics 42:11, pages e220-e241.
Crossref
Rezvan Rahimi & Mohammad Solimannejad. (2020) BC3 graphene-like monolayer as a drug delivery system for nitrosourea anticancer drug: A first-principles perception. Applied Surface Science 525, pages 146577.
Crossref
Mehrnoosh Khodam Hazrati, Zargham Bagheri & Ali Bodaghi. (2017) Application of C 30 B 15 N 15 heterofullerene in the isoniazid drug delivery: DFT studies. Physica E: Low-dimensional Systems and Nanostructures 89, pages 72-76.
Crossref
Kanumuri Siva Rama Raju, Manoj Gundeti, Mohd Yaseen Malik, Naveen Kadian, Mamunur Rashid, Isha Taneja, Sheelendra Pratap Singh & Muhammad Wahajuddin. (2017) Bioanalysis of antitubercular drugs using liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 134, pages 295-309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.